In honor of the occasion, Tien Lee, M.D., CEO & Founder, rings the Closing Bell. Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered ...
It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results